The elevated markers of hypercoagulability in children with Henoch-Schönlein purpura
dc.contributor.author | Yilmaz D. | |
dc.contributor.author | Kavakli K. | |
dc.contributor.author | Ozkayin N. | |
dc.date.accessioned | 2019-10-27T00:11:48Z | |
dc.date.available | 2019-10-27T00:11:48Z | |
dc.date.issued | 2005 | |
dc.department | Ege Üniversitesi | en_US |
dc.description.abstract | Twenty-eight children with HSP and 79 healthy children were entered into study. Activities of protein C, free-protein S and antithrombin, activated protein C resistance, levels of fibrinogen. D-dimer, thrombin-antithrombin complex (TAT), prothrombin fragments 1+2 (PF1+2), and von Willebrand factor antigen (vWAg) and its activity (RiCof) were investigated in acute and recovery phases of HSP and controls. Fibrinogen, D-dimer, TAT, PF1+2, vWAg, and RiCof levels in patients with HSP during the acute phase were significantly higher than those of recovery phase and of the controls. A significant correlation was detected between severity of disease and TAT, PF1+2, vWAg, and D-dimer levels. | en_US |
dc.identifier.doi | 10.1080/08880010590896251 | en_US |
dc.identifier.endpage | 48 | en_US |
dc.identifier.issn | 0888-0018 | |
dc.identifier.issue | 1 | en_US |
dc.identifier.pmid | 15770830 | en_US |
dc.identifier.scopusquality | Q3 | en_US |
dc.identifier.startpage | 41 | en_US |
dc.identifier.uri | https://doi.org/10.1080/08880010590896251 | |
dc.identifier.uri | https://hdl.handle.net/11454/22239 | |
dc.identifier.volume | 22 | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.relation.ispartof | Pediatric Hematology and Oncology | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Child | en_US |
dc.subject | Henoch-Schönlein purpura | en_US |
dc.subject | Hypercoagulability | en_US |
dc.title | The elevated markers of hypercoagulability in children with Henoch-Schönlein purpura | en_US |
dc.type | Article | en_US |